RhumbLine Advisers’s Rockwell Medical RMTI Stock Holding History

RhumbLine Advisers’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-673	Closed	-$86K	–	3091
2021 Q1	$86K	Sell	673 -111	-14%	-$16.4K	﹤0.01%	2947
2020 Q4	$87K	Buy	784 +153	+24%	+$17.1K	﹤0.01%	2978
2020 Q3	$74K	Sell	631 -137	-18%	-$23.7K	﹤0.01%	2921
2020 Q2	$165K	Sell	768 -6	-0.8%	-$1.42K	﹤0.01%	2836
2020 Q1	$175K	Hold	774	–	–	﹤0.01%	2634
2019 Q4	$208K	Buy	774 +37	+5%	+$9.3K	﹤0.01%	2733
2019 Q3	$224K	Buy	737 +16	+2%	+$4.92K	﹤0.01%	2706
2019 Q2	$239K	Buy	721 +153	+27%	+$77.7K	﹤0.01%	2716
2019 Q1	$355K	Sell	568 -18	-3%	-$8.21K	﹤0.01%	2461
2018 Q4	$146K	Buy	586 +188	+47%	+$74.8K	﹤0.01%	2819
2018 Q3	$185K	Sell	398 -25	-6%	-$12.1K	﹤0.01%	2752
2018 Q2	$230K	Buy	423 +24	+6%	+$14.4K	﹤0.01%	2671
2018 Q1	$228K	Sell	399 -12	-3%	-$7.57K	﹤0.01%	2553
2017 Q4	$263K	Sell	411 -78	-16%	-$54.9K	﹤0.01%	2521
2017 Q3	$460K	Buy	489 +6	+1%	+$4.59K	﹤0.01%	2351
2017 Q2	$422K	Sell	483 -10	-2%	-$8.19K	﹤0.01%	2384
2017 Q1	$340K	Buy	493 +15	+3%	+$9.88K	﹤0.01%	2444
2016 Q4	$345K	Sell	478 -31	-6%	-$21.4K	﹤0.01%	2424
2016 Q3	$375K	Buy	509 +8	+2%	+$6.48K	﹤0.01%	2366
2016 Q2	$418K	Buy	501 +42	+9%	+$39.1K	﹤0.01%	2318
2016 Q1	$379K	Buy	459 +6	+1%	+$4.71K	﹤0.01%	2398
2015 Q4	$510K	Buy	453 +34	+8%	+$39.6K	﹤0.01%	2232
2015 Q3	$355K	Buy	419 +17	+4%	+$24.6K	﹤0.01%	2440
2015 Q2	$713K	Sell	402 -116	-22%	-$147K	﹤0.01%	2093
2015 Q1	$623K	Buy	518 +72	+16%	+$84.3K	﹤0.01%	2163
2014 Q4	$504K	Buy	446 +28	+7%	+$28.7K	﹤0.01%	2272
2014 Q3	$420K	Sell	418 -1	-0.2%	-$1.13K	﹤0.01%	2322
2014 Q2	$552K	Buy	419 +8	+2%	+$9.62K	﹤0.01%	2213
2014 Q1	$572K	Sell	411 -17	-4%	-$22.1K	﹤0.01%	2137
2013 Q4	$491K	Sell	428 -28	-6%	-$38.6K	﹤0.01%	2269
2013 Q3	$573K	Sell	456 -4	-0.9%	-$2.71K	﹤0.01%	2128
2013 Q2	$183K	Buy	+460	New	+$195K	﹤0.01%	3027

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

RhumbLine Advisers's RMTI Position: Q2 2021 in Review

RhumbLine Advisers sold out of Rockwell Medical (RMTI) in Q2 2021, closing a stake of 673 shares — an estimated $86K sold.

RhumbLine Advisers first reported a position in RMTI in Q2 2013 and held it in 32 quarters. The position peaked at $713K in Q2 2015. 78 funds tracked by Wall St. Rank hold RMTI as of Q2 2021.

RhumbLine Advisers reported no remaining Rockwell Medical position as of Q2 2021 after selling out during the quarter.
RhumbLine Advisers sold 673 Rockwell Medical shares in Q2 2021, an estimated $86K.
RhumbLine Advisers first reported a position in Rockwell Medical in Q2 2013 and held it in 32 quarters.
RhumbLine Advisers's Rockwell Medical position peaked at $713K in Q2 2015.
78 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2021.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.